Lung Neoplasms: all 7,334 studies

Page 27 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.

• Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00495040Phase 2Results posted
• Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC)TerminatedNCT00494026Phase 2Results posted
• Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLCCompletedNCT00492206Phase 2Results posted
• Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT00487669Phase 2Results posted
• A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung CancerCompletedNCT00482014Phase 1/2Results posted
• Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00481078Phase 2Results posted
• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung CancerTerminatedNCT00480025Phase 3Results posted
• Randomized Customized Adjuvant Chemotherapy (GECP-SCAT)CompletedNCT00478699Phase 3Results posted
• Pemetrexed and Cisplatin as Treatment in Small Cell Lung CancerTerminatedNCT00475657Phase 2Results posted
• A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056)TerminatedNCT00473889Phase 2/3Results posted
• Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung CancerCompletedNCT00473083Phase 2Results posted
• Abraxane and Alimta in Advanced Solid TumorsTerminatedNCT00470548Phase 1/2Results posted
• Dasatinib in Treating Patients With Relapsed Small Cell Lung CancerCompletedNCT00470054Phase 2Results posted
• Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00469898Phase 2Results posted
• Pazopanib in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00459862Phase 2Results posted
• Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00459342Phase 2Results posted
• Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by SurgeryTerminatedNCT00459121Phase 2Results posted
• A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib AloneCompletedNCT00457392Phase 3Results posted
• First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLCCompletedNCT00456261Phase 2Results posted
• Study of Abraxane and Carboplatin to Treat Small Cell Lung CancerTerminatedNCT00454324Phase 2Results posted
• Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00454194Phase 2Results posted
• A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With ErlotinibCompletedNCT00453362Phase 1/2Results posted
• A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung CancerCompletedNCT00452413Phase 1/2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.CompletedNCT00451906Phase 4Results posted
• A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and RadiotherapyTerminatedNCT00447421Phase 1/2Results posted
• Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFRCompletedNCT00446225Phase 3Results posted
• Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerCompletedNCT00445965Phase 2Results posted
• S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung CancerCompletedNCT00445848Phase 2Results posted
• Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTerminatedNCT00438204Phase 2Results posted
• S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar CarcinomaCompletedNCT00436332Phase 2Results posted
• A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)TerminatedNCT00434226Phase 2Results posted
• A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.CompletedNCT00428220Not applicableResults posted
• Phase I/II Study to Evaluate the Efficacy and Safety of a Combination ChemotherapyTerminatedNCT00424840Phase 1Results posted
• A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066)TerminatedNCT00424775Phase 1Results posted
• Clinical Trial of MK0683 in Combination With FDA Approved Cancer Drugs in Patients With Advanced NSCLC (MK0683-058)CompletedNCT00423449Phase 1Results posted
• Interactive Voice Response (IVR) Symptom Assessment in Non-Small Cell Lung Cancer (NSCLC) PatientsCompletedNCT00423436Not applicableResults posted
• Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC PatientsCompletedNCT00418886Phase 3Results posted
• Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung CancerTerminatedNCT00417248Phase 1/2Results posted
• Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation TherapyCompletedNCT00415363Phase 2Results posted
• A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former SmokersCompletedNCT00414960Phase 2Results posted
• Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00413283Phase 2Results posted
• BATTLE Program: Sorafenib in Patients With NSCLCCompletedNCT00411671Phase 2Results posted
• BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00411632Phase 2Results posted
• AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung CancerCompletedNCT00410904Phase 2Results posted
• BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLCCompletedNCT00410189Phase 2Results posted
• BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLCCompletedNCT00410059Phase 2Results posted
• Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)CompletedNCT00409188Phase 3Results posted
• Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-SmokersCompletedNCT00409006Phase 2Results posted
• Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung CancerCompletedNCT00408499Phase 1/2Results posted
• Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00408460Phase 2Results posted
• Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00407550Phase 2Results posted
• Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung CancerTerminatedNCT00406276Phase 1/2Results posted
• ZD6474 (ZACTIMA™) Phase III Study in EGFR FailuresCompletedNCT00404924Phase 3Results posted
• A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE)CompletedNCT00403403Phase 2Results posted
• Malignant Pleural Effusion With ZD6474TerminatedNCT00402896Phase 2Results posted
• Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung CancerTerminatedNCT00402883Phase 2Results posted
• Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00402051Phase 2Results posted
• Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00401778Phase 1Results posted
• E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00400829Phase 2Results posted
• Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or MesotheliomaCompletedNCT00398138Phase 1Results posted
• Sunitinib in Treating Patients With Advanced Malignant Pleural MesotheliomaCompletedNCT00392444Phase 2Results posted
• Erlotinib and Standard Platinum-Based Chemotherapy for Newly Diagnosed, Advanced Non-Small Cell Carcinoma of the LungTerminatedNCT00391586Phase 2Results posted
• Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00391274Phase 3Results posted
• Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung CancerCompletedNCT00390806Phase 3Results posted
• Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsCompletedNCT00390429Phase 1/2Results posted
• Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsCompletedNCT00389805Phase 1/2Results posted
• Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung CancerCompletedNCT00387660Phase 2Results posted
• Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung CancerCompletedNCT00387465Phase 1/2Results posted
• Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal CancerTerminatedNCT00387348Phase 3Results posted
• Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non Small Cell Lung CancerTerminatedNCT00383331Phase 2Results posted
• Chemotherapy for Patients With Non-Small Cell Lung CancerCompletedNCT00380718Phase 4Results posted
• Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung CancerTerminatedNCT00378573Phase 2Results posted
• Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesCompletedNCT00377156Phase 3Results posted
• Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung CancerCompletedNCT00374140Phase 2Results posted
• A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive TumorsCompletedNCT00373425Phase 3Results posted
• Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain MetastasesCompletedNCT00372775Phase 2Results posted
• Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00370292Phase 2Results posted
• S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00368992Phase 2Results posted
• Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial DysplasiaCompletedNCT00368927Phase 2Results posted
• Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung CancerCompletedNCT00367679Phase 2Results posted
• Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung CancerCompletedNCT00367601Phase 2Results posted
• Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic ChemotherapyCompletedNCT00365547Phase 2Results posted
• Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit SmokingCompletedNCT00365508Phase 4Results posted
• Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast CancerCompletedNCT00365105Phase 3Results posted
• PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By SurgeryCompletedNCT00365053Phase 2Results posted
• Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior ChemotherapyCompletedNCT00364351Phase 3Results posted
• Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary DiseaseCompletedNCT00363805Phase 2Results posted
• Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung CancerCompletedNCT00363766Phase 2Results posted
• Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung CancerCompletedNCT00362882Phase 2Results posted
• Iressa Follow-up TrialCompletedNCT00357734Phase 3Results posted
• Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After Previous Chemotherapy and Surgical Removal of the NSCLC TumorTerminatedNCT00356525Phase 2Results posted
• Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00356122Phase 2Results posted
• Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung CancerTerminatedNCT00351039Phase 1/2Results posted
• Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly PatientsCompletedNCT00350792Phase 2Results posted
• First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) MutationCompletedNCT00344773Phase 2Results posted
• A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLCCompletedNCT00343291Phase 2Results posted
• ZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for Advanced Non-Small Cell Lung CancerCompletedNCT00328562Phase 1Results posted
• Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00326599Phase 2Results posted
• Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung CancerCompletedNCT00323869Phase 2Results posted
• Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung CancerTerminatedNCT00323362Phase 2Results posted

← Lung Neoplasms overview